Artificial intelligence in inflammatory bowel disease

Area of Science:

• Gastroenterology and Computational Biology
• Focuses on the intersection of artificial intelligence and inflammatory bowel disease research.

Background:

• Inflammatory bowel disease (IBD) is a complex gastrointestinal condition with multifactorial causes.
• Recent advancements in omics and network technologies have accelerated IBD research.
• Artificial intelligence (AI) offers powerful tools for interpreting large biological datasets.

Purpose of the Study:

• To review the principles of AI and its current applications in IBD research.
• To explore the potential of AI in advancing targeted treatment strategies for IBD.
• To highlight AI's role in improving diagnostic accuracy and patient management in gastroenterology.

Main Methods:

• Review of current literature on AI applications in gastroenterology and IBD.
• Analysis of AI's utility in endoscopic analyses, including cancer and polyp detection.
• Examination of AI's role in patient stratification and treatment response prediction.

Main Results:

• AI enhances the interpretation of complex datasets in IBD research.
• AI assists in endoscopic diagnosis of colorectal cancer, polyps, and inflammatory lesions.
• AI supports personalized patient management, including predicting disease progression and treatment response.

Conclusions:

• AI integration in IBD research accelerates the discovery of actionable insights.
• AI-driven approaches promise to optimize treatment strategies and improve patient outcomes.
• The future of IBD management will likely involve significant AI contributions for personalized medicine.